Daniel C. Liebler received a B.S. degree in Chemistry from Villanova University and a Ph.D. in Pharmacology from Vanderbilt University. After postdoctoral training in Biochemistry at Oregon State University, he joined the faculty at the University of Arizona in 1987 and rose to the rank of Professor and Director of the Southwest Environmental Health Sciences Center. He returned to Vanderbilt in May 2003. Dr. Liebler is Ingram Professor of Cancer Research and Professor of Biochemistry, Pharmacology and Biomedical Informatics at Vanderbilt University School of Medicine. Dr. Liebler’s research program has focused for over 20 years on the interactions of chemicals with biological systems, including studies of antioxidant chemistry and its expression in biological systems, the development of methods to analyze modified and damaged proteins and the impact of protein damage by reactive chemicals. A major theme of this work has been the application of mass spectrometry technology to probe the chemistry-biology interface. In January 2006, he was appointed Director of the Jim Ayers Institute for Precancer Detection and Diagnosis, which is dedicated to the application of proteomic technologies to develop cancer diagnostics. Dr. Liebler is Director of the Vanderbilt programs in the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) and Early Detection Research Network (EDRN). He is an Associate Editor of Molecular and Cellular Proteomics and has served on the editorial boards of Chemical Research in Toxicology, and the Journal of Proteome Research. He was a member of the NIH Chemical Pathology Study Section (1994-1998; Chair, 1996-1998) and the National Advisory Environmental Health Sciences Council (2005-2009). Dr. Liebler serves as a member of the scientific expert panels for the Cosmetic Ingredient Review and the Research Institute for Fragrance Manufacturers. He was elected a Fellow of the American Association for the Advancement of Science in 2008 and was the recipient of the 2009 North American Scientific Achievement Award from the International Society for the Study of Xenobiotics.